These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 10050982)

  • 1. Evaluation of clinical benefit of chemotherapy in patients with upper gastrointestinal cancer.
    Hoffman K; Glimelius B
    Acta Oncol; 1998; 37(7-8):651-9. PubMed ID: 10050982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer.
    Glimelius B; Hoffman K; Sjödén PO; Jacobsson G; Sellström H; Enander LK; Linné T; Svensson C
    Ann Oncol; 1996 Aug; 7(6):593-600. PubMed ID: 8879373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical benefit response in pancreatic cancer trials revisited.
    Bernhard J; Dietrich D; Glimelius B; Bodoky G; Scheithauer W; Herrmann R
    Oncol Res Treat; 2014; 37(1-2):42-8. PubMed ID: 24613908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of the measure of ovarian symptoms and treatment concerns: aiming for optimal measurement of patient-reported symptom benefit with chemotherapy for symptomatic ovarian cancer.
    King MT; Stockler MR; Butow P; O'Connell R; Voysey M; Oza AM; Gillies K; Donovan HS; Mercieca-Bebber R; Martyn J; Sjoquist K; Friedlander ML
    Int J Gynecol Cancer; 2014 Jun; 24(5):865-73. PubMed ID: 24844220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current aspects of chemotherapy of metastatic pancreatic and biliary tract carcinomas].
    Bokemeyer C; Kollmannsberger C; Oettle H; Kanz L
    Praxis (Bern 1994); 2000 Sep; 89(39):1545-52. PubMed ID: 11068508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of therapeutic effect of chemotherapy with reference to clinical benefit response].
    Okada S
    Gan To Kagaku Ryoho; 2000 May; 27(5):696-701. PubMed ID: 10832437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas.
    Choi CW; Choi IK; Seo JH; Kim BS; Kim JS; Kim CD; Um SH; Kim JS; Kim YH
    Am J Clin Oncol; 2000 Aug; 23(4):425-8. PubMed ID: 10955877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.
    Mortensen MB
    Dan Med J; 2012 Dec; 59(12):B4568. PubMed ID: 23290296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Possibilities of palliation in pancreatic cancer].
    Di Costanzo F; Sdrobolini A; Gasperoni S
    Tumori; 1999; 85(1 Suppl 1):S47-53. PubMed ID: 10235081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combination chemotherapy of UFT with adriamycin in advanced gastrointestinal cancer].
    Koda K; Kure T; Terada S; Arai R; Morita K; Hirayama M; Terui T; Fukushi A; Yoshizaki N; Nakazawa O
    Gan No Rinsho; 1987 Sep; 33(11):1329-35. PubMed ID: 3118075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prospective randomized trial comparing 1/2 FAM (5-fluorouracil (5-FU) + adriamycin + mitomycin C) versus palliative therapy for the treatment of unresectable pancreatic and biliary tract carcinomas (the 2nd trial in non-resectable patients). Japanese Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract].
    Takada T; Kato H; Matsushiro T; Nimura Y; Nagakawa T; Nakayama T; Yamauchi H; Ogata Y; Shimada H; Miyakawa S; Yamaguchi A; Sakoda K; Yasuda H; Tsukada K; Yoshida K; Ashida H; Ishikawa Y; Kotoura Y; Kinoshita H; Kajiwara T; Watanabe G; Uchimura M; Funabiki T; Ikeda S; Okada S
    Gan To Kagaku Ryoho; 1996 May; 23(6):707-14. PubMed ID: 8645022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 5-fluorouracil, doxorubicin and mitomycin C with 5-fluorouracil alone in the treatment of pancreatic-biliary carcinomas.
    Takada T; Kato H; Matsushiro T; Nimura Y; Nagakawa T; Nakayama T
    Oncology; 1994; 51(5):396-400. PubMed ID: 8052479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOLFIRI in patients with locally advanced or metastatic pancreatic or biliary tract carcinoma: a monoinstitutional experience.
    Moretto R; Raimondo L; De Stefano A; Cella CA; Matano E; De Placido S; Carlomagno C
    Anticancer Drugs; 2013 Oct; 24(9):980-5. PubMed ID: 23928570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of outcomes in patients undergoing covered and uncovered self-expandable metal stent placement for malignant gastric outlet obstruction: a multicenter study.
    Hori Y; Naitoh I; Hayashi K; Ban T; Natsume M; Okumura F; Nakazawa T; Takada H; Hirano A; Jinno N; Togawa S; Ando T; Kataoka H; Joh T
    Gastrointest Endosc; 2017 Feb; 85(2):340-348.e1. PubMed ID: 27475489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptom burden and outcomes of patients with platinum resistant/refractory recurrent ovarian cancer: a reality check: results of stage 1 of the gynecologic cancer intergroup symptom benefit study.
    Friedlander ML; Stockler M; O'Connell R; Voysey M; Oza A; Gillies K; Donovan H; Martyn J; Sjoquist K; Butow P; King MT;
    Int J Gynecol Cancer; 2014 Jun; 24(5):857-64. PubMed ID: 24844219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-dose etoposide in advanced pancreatic and biliary cancer, a phase II study.
    Ekstrom K; Hoffman K; Linne T; Eriksson B; Glimelius B
    Oncol Rep; 1998; 5(4):931-4. PubMed ID: 9625849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A metronomic schedule as salvage chemotherapy for upper gastrointestinal tract cancer.
    Roberto M; Romiti A; Onesti CE; D'Antonio C; Milano A; Falcone R; Barucca V; Palombi L; Righini R; Marchetti P
    Anticancer Drugs; 2016 Feb; 27(2):106-11. PubMed ID: 26473528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival and quality of life in gastrointestinal tumors: two different end points?
    Cascinu S; Labianca R; Daniele B; Beretta G; Salvagni S
    Ann Oncol; 2001; 12 Suppl 3():S31-6. PubMed ID: 11804382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does palliative chemotherapy palliate? Evaluation of expectations, outcomes, and costs in women receiving chemotherapy for advanced ovarian cancer.
    Doyle C; Crump M; Pintilie M; Oza AM
    J Clin Oncol; 2001 Mar; 19(5):1266-74. PubMed ID: 11230467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.